Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jason B. White"'
Autor:
Anne V. Philips, Jason B White, Jennifer A. Wargo, Sahil Seth, Xiangjie Sun, Senthil Damodaran, Andrew Futreal, Gabriel N. Hortobagyi, Er-Yen Yen, Clinton Yam, Baohua Sun, Gheath Alatrash, Stacy L. Moulder, Qingqing Ding, Edwin Roger Parra Cuentas, Ignacio I. Wistuba, Fei Yang, Elizabeth A. Mittendorf, Jeffrey T. Chang, Elizabeth Ravenberg, Haven R. Garber, Jennifer L. Guerriero, Bora Lim, Jennifer K. Litton, Ryan Sun, Lei Huo, Kasthuri Kannan, Naoto T. Ueno, Roland L. Bassett, Gaiane M. Rauch, William Fraser Symmans
Publikováno v:
Clin Cancer Res
Purpose: Increasing tumor-infiltrating lymphocytes (TIL) is associated with higher rates of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in patients with triple-negative breast cancer (TNBC). However, the presence of TILs does not
Autor:
Peng Wei, Wei T. Yang, Lumarie Santiago, Marion E. Scoggins, Rosalind P. Candelaria, Alastair M. Thompson, Gary J. Whitman, Beatriz E. Adrada, Tanya W. Moseley, Jason B White, Vicente Valero, Stacy L. Moulder, Elizabeth Ravenberg, Jennifer K. Litton, Gaiane M. Rauch
Publikováno v:
Cancer
BACKGROUND Heterogeneity exists in the response of triple-negative breast cancer (TNBC) to standard anthracycline (AC)/taxane-based neoadjuvant systemic therapy (NAST), with 40% to 50% of patients having a pathologic complete response (pCR) to therap
Autor:
Jessica W.T. Leung, Rosalind P. Candelaria, Jong Bum Son, Elsa Arribas, Peng Wei, Hagar S. Mahmoud, Jingfei Ma, Marion E. Scoggins, Kenneth R. Hess, Jennifer K. Litton, Abeer H Abdelhafez, Stacy L. Moulder, Vicente Valero, Elizabeth Ravenberg, Alastair M. Thompson, Gary J. Whitman, Huong T. Le-Petross, Beatriz E. Adrada, Tanya W. Moseley, Mark D. Pagel, Gaiane M. Rauch, Deanna L. Lane, Benjamin C. Musall, Ken Pin Hwang, Jason B White, Lumarie Santiago, Wei T. Yang
Publikováno v:
Breast Cancer Res Treat
PURPOSE: To determine if tumor necrosis by pretreatment breast MRI and its quantitative imaging characteristics are associated with response to NAST in TNBC. METHODS: This retrospective study included 85 TNBC patients (mean age 51.8 ± 13 years) with
Autor:
Funda Meric-Bernstam, Rosalind P. Candelaria, Jennifer K. Litton, Gaiane M. Rauch, Beatriz E. Adrada, Colleen T. Eppig, Debu Tripathy, Kenneth R. Hess, Senthil Damodaran, Stacy L. Moulder, Bora Lim, Krzysztof J. Grzegorzewski, Ignacio I. Wistuba, Jason B White
Publikováno v:
Cancer Research. 80:OT2-06
Background:While TNBC patients with pathologic complete response (pCR) or residual cancer burden (RCB-I) have good survival rates, those with extensive residual disease (RCB-II or RCB-III) after neoadjuvant chemotherapy (NACT) have poor prognosis. Pa
Autor:
Benjamin C. Musall, Shu Zhang, Jingfei Ma, Mitsuharu Miyoshi, Xinzeng Wang, Ken-Pin Hwang, Mark D. Pagel, Nabil Elshafeey, Aikaterini Kotrotsou, Rania M.M Mohamed, Abeer H Abdelhafez, Peng Wei, Jia Sun, Medine Boge, Beatriz E. Adrada, Jason B White, Gaiane M. Rauch, Jong Bum Son
Publikováno v:
Radiol Imaging Cancer
PURPOSE: To determine if amide proton transfer–weighted chemical exchange saturation transfer (APT(W) CEST) MRI is useful in the early assessment of treatment response in persons with triple-negative breast cancer (TNBC). MATERIALS AND METHODS: In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04b3c571b0788a07b0128c5da996a704
https://europepmc.org/articles/PMC8489465/
https://europepmc.org/articles/PMC8489465/
Autor:
Rosalind P. Candelaria, Stacy L. Moulder, A David, Shu Zhang, Hagar S. Mahmoud, Huong T. Le-Petross, Deanna L. Lane, Mark D. Pagel, Ken Pin Hwang, Gaiane M. Rauch, Beatriz E. Adrada, Jingfei Ma, Jia Sun, Nabil Elshafeey, Alastair M. Thompson, Jong Bum Son, Peng Wei, Elizabeth Ravenberg, Elsa Arribas, Jason B White, Wei T. Yang, Jessica W.T. Leung, Rania M.M Mohamed, Abeer H Abdelhafez, Benjamin C. Musall, Senthil Damodaran, Jennifer K. Litton, Medine Boge
Publikováno v:
Journal of magnetic resonance imaging : JMRIReferences. 54(1)
BACKGROUND Dynamic contrast-enhanced (DCE) MRI is useful for diagnosis and assessment of treatment response in breast cancer. Fast DCE MRI offers a higher sampling rate of contrast enhancement curves in comparison to conventional DCE MRI, potentially
Autor:
Timothy P. Heffernan, Ningping Feng, Jason B White, Jeffrey T. Chang, Xiao Yan Ma, Yizheng Tu, W. Fraser Symmans, Virginia Giuliani, Shirong Cai, Xuan Liu, Clifford Stephan, Xinhui Zhou, Reid T. Powell, Lei Guo, Joseph R. Marszalek, Christopher P. Vellano, Abena B. Redwood, Stacy L. Moulder, Helen Piwnica-Worms, Peter J.A. Davies, Yuan Qi, Gloria V. Echeverria, Yan Jiang, Xiaomei Zhang
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports
Scientific Reports
Triple-negative breast cancer (TNBC) accounts for 15–20% of breast cancer cases in the United States, lacks targeted therapeutic options, and is associated with a 40–80% risk of recurrence. Thus, identifying actionable targets in treatment-naïve
Autor:
Rosalind P. Candelaria, Elsa Arribas, Vicente Valero, Monica L. Huang, Jason B White, Stacy L. Moulder, Jessica W.T. Leung, Lumarie Santiago, Wei Tse Yang, Gaiane M. Rauch, Deanna L. Lane, W. Fraser Symmans, Kenneth R. Hess, Alastair M. Thompson, Beatriz E. Adrada, Elizabeth Ravenberg
Publikováno v:
Eur J Radiol
PURPOSE: To investigate the value of performing mid-treatment axillary ultrasound (AUS) in triple-negative breast cancer (TNBC) patients who are undergoing neoadjuvant systemic therapy (NAST) by determining the optimal cutoff number of abnormal nodes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c718d57ed91caf863d01ff4e770b66f
https://europepmc.org/articles/PMC7534548/
https://europepmc.org/articles/PMC7534548/
Autor:
Vicente Valero, Bora Lim, Lei Huo, Ryan Sun, Alastair M. Thompson, Aysegul A. Sahin, Nuhad K. Ibrahim, Elizabeth Ravenberg, Clinton Yam, Rashmi Krishna Murthy, Elizabeth A. Mittendorf, Stacy L. Moulder, Banu Arun, Jason B White, Debu Tripathy, Senthil Damodaran, Beatriz E. Adrada, Anthony Lucci, Nour Abuhadra, Naoto T. Ueno, Jennifer K. Litton, Jeffrey T. Chang, Gabriel N. Hortobagyi
Publikováno v:
Cancer Research. 81:PS18-04
Background: MpBC is a rare breast cancer subtype that is commonly triple-negative and associated with a diminished response to NAT in published retrospective data sets, prompting some clinicians to recommend surgical resection followed by adjuvant th